Skip to main content
Compass Pathways - Compassion Navigation Mental Health Pathways logo
  • About us
        • About us

          COMPASS Pathways is a mental health care company. We are dedicated to accelerating patient access to evidence-based innovation in mental health.

        • About us
          • Why we exist
          • Our values
          • Our approach
        • Our team
          • Executive Team
          • Board of Directors
          • Scientific Advisory Network
        • Annual Review 2021

          In 2021 we took a giant leap forward in our work to transform mental health care.

          Read about our progress
  • Our work
        • Our work

          We want to find better ways to support people suffering with mental health challenges, and we believe we’re onto something important.

        • About psilocybin therapy
        • Pipeline
          • Treatment-resistant depression (TRD)
          • Post-traumatic stress disorder (PTSD)
          • Anorexia nervosa
          • Pipeline overview
          • Investigator-initiated studies
        • Therapist training
          • About our therapist training
        • Preclinical research
          • Discovery Center
          • Other research partnerships
        • Our publications and results
          • COMP360 psilocybin in healthy participants
          • COMP360 psilocybin therapy in TRD
          • COMP360 psilocybin therapy in TRD with antidepressants
          • Therapist training: Frontiers in Psychiatry
        • Our approach
          • Centres of Excellence
          • Compassionate use policy
          • Animal welfare
          • Partnerships and grants
          • Digital technologies
        • COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa

          Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which there is currently no approved pharmacological treatment option.

          Read more
  • Join us
        • Join us

          Here at COMPASS, we are united by our commitment to improving patient experience and outcomes in mental health care.

        • Join us
          • Working at COMPASS
          • Careers
          • Our graduate programme
          • 60 seconds with ...
        • Header with photos of members of the COMPASS team
        • Our graduate programme

          We are launching a graduate programme in Research and Development, which will offer life science graduates the opportunity to kickstart a career at COMPASS.

          Find out more
  • News & views
        • News & views

          Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.

        • All news & views
          • COMPASS news
          • Our perspectives
          • Our stories
          • Podcast
          • White Paper
          • COMPASS news archive
        • COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

          Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental health care

          Read more
  • Investors
        • Investors

          We are COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.

        • News & events
          • News releases
          • Events
          • Presentations
          • SEC filings & annual reports
          • Our annual review
        • Stock information
          • Stock quote & chart
          • Historical price lookup
          • Analyst Coverage
          • Split history
        • Corporate governance
          • Documents & charters
          • Executive Team
          • Board of directors
          • Committee composition
          • Annual general meeting
        • Investor resources
          • Shareholder privacy notice
          • FAQs
          • Email alerts and RSS feeds
          • IR contact
        • COMP360 psilocybin therapy in TRD

          We have completed the largest randomised, controlled, double-blind psilocybin therapy study ever done.

          Read more
  • Responsibility
        • Responsibility

          We are building a sustainable business that supports patients, health systems, and society in a way that reflects our values.

        • Responsibility
          • Patients
          • Science
          • Community
        • About us

          We have put a lot of thought into the kind of organisation we want to be, and make every decision with our four values in mind.

          Read more
  • LinkedIn
  • Youtube
  • Accessibility
accessibility optionsAccessibility options
  • High Contrast
  • Greyscale
  • Negative Contrast
  • Readable
  • Reset

Accessibility

High Contrast

Greyscale

Negative Contrast

Readable

Back to home
  1. Home
  2. Accessibility
This website is hosted Green - checked by thegreenwebfoundation.org

This website is powered by renewable energy

Useful links
  • Contact us
  • Our results
  • About psilocybin therapy
  • About us
  • Join us
  • News & views
  • Annual Review 2021
Follow us
  • LinkedIn
  • Youtube

Sign up to receive the latest COMPASS news.

Subscribe
  • Unsolicited Information Policy
  • Terms
  • Privacy
  • myPathfinder privacy

COMPASS © 2022. All rights reserved.

The press releases and articles contained in this section are provided for historical purposes only. The information contained in each press release and article is accurate only as of the date each press release and article was originally issued. COMPASS disavows any obligation to update the information contained in such press releases and articles after the date of their issuance.

You are now leaving COMPASS Pathways’ website.

COMPASS does not control and is not responsible for the content on the website you are about to visit. COMPASS is providing this link as a convenience, and this link does not imply COMPASS endorsement of any material on the website you are about to visit. Do you wish to continue?

This site uses functional cookies and external scripts to improve your experience.

Privacy settings

Privacy Settings

This site uses functional cookies and external scripts to improve your experience. Which cookies and scripts are used and how they impact your visit is specified on the left. You may change your settings at any time. Your choices will not impact your visit.

NOTE: These settings will only apply to the browser and device you are currently using.

More Information

If you would like to know more about Cookie Notices and Cookie Consent click here

Functional

These cookies are required for basic site functionality and are therefore always enabled. These include cookies that allow you to be remembered as you explore the site within a single session or, if you request, from session to session. They help make the shopping cart and checkout process possible as well as assist in security issues and conforming to regulations.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but if you do so, some parts of the site will not work. These cookies do not store any personal information.

Powered by Cookie Information